Search research articles
Contact Us
Filters
Showing results (371-380 of 461) with videos related to
Page
of 47
Sort By:
Frontiers in Neurology
|
February 15, 2019
Extracranial and Intracranial Vasculopathy With "Moyamoya Phenomenon" in Association With Alagille Syndrome
Siobhan Delaney, Ged O'Connor, William Reardon, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
February 1, 1996
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
S de Sanjosé, N Muñoz, G Sobala, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 14, 2018
Population-based study of "no evident disease activity" in MS
Natalie E Parks, Sean J Pittock, Jay Mandrekar, et al.
Journal of Neuroimmunology
|
March 26, 2025
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis
Burcu Zeydan, Nur Neyal, Nabeela Nathoo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 8, 2025
Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination
Hannah H Zhao-Fleming, Paul A Decker, Matthew L Kosel, et al.
European Journal of Neurology
|
October 26, 2024
Central nervous system crystal-storing histiocytosis: A case report and literature review
Nabeela Nathoo, Daniel P Larson, Yong Guo, et al.
Nature Communications
|
December 19, 2018
The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity
Jordan R Becker, Raquel Cuella-Martin, Marco Barazas, et al.
Plos One
|
January 30, 2016
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
Lynne Hampson, Innocent O Maranga, Millicent S Masinde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2010
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer
David S Ettinger, Robert Jotte, Paul Lorigan, et al.
Bioorganic & Medicinal Chemistry
|
December 22, 2009
Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2
Stephen Hilton, Sebastien Naud, John J Caldwell, et al.
Page
of 47
Search research articles
Search
Showing results (371-380 of 461) with videos related to
Sort By:
Page
of 47
Frontiers in Neurology
|
February 15, 2019
Extracranial and Intracranial Vasculopathy With "Moyamoya Phenomenon" in Association With Alagille Syndrome
Siobhan Delaney, Ged O'Connor, William Reardon, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
February 1, 1996
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
S de Sanjosé, N Muñoz, G Sobala, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 14, 2018
Population-based study of "no evident disease activity" in MS
Natalie E Parks, Sean J Pittock, Jay Mandrekar, et al.
Journal of Neuroimmunology
|
March 26, 2025
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis
Burcu Zeydan, Nur Neyal, Nabeela Nathoo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 8, 2025
Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination
Hannah H Zhao-Fleming, Paul A Decker, Matthew L Kosel, et al.
European Journal of Neurology
|
October 26, 2024
Central nervous system crystal-storing histiocytosis: A case report and literature review
Nabeela Nathoo, Daniel P Larson, Yong Guo, et al.
Nature Communications
|
December 19, 2018
The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity
Jordan R Becker, Raquel Cuella-Martin, Marco Barazas, et al.
Plos One
|
January 30, 2016
A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease
Lynne Hampson, Innocent O Maranga, Millicent S Masinde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2010
Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer
David S Ettinger, Robert Jotte, Paul Lorigan, et al.
Bioorganic & Medicinal Chemistry
|
December 22, 2009
Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2
Stephen Hilton, Sebastien Naud, John J Caldwell, et al.
Page
of 47